Specific risk scores for specific purposes: Use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation

被引：9
|
作者：
Dzeshka, Mikhail S. [1 ,2 ]
Lip, Gregory Y. H. [1 ,3 ]
机构：
[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
[2] Grodno State Med Univ, Grodno, BELARUS
[3] Aalborg Univ, Dept Clin Med, Thrombosis Res Unit, Aalborg, Denmark
来源：
THROMBOSIS RESEARCH | 2014年 / 134卷 / 02期
关键词：
VITAMIN-K ANTAGONISTS; ANTICOAGULATED PATIENTS; PREDICTION; CHADS(2); ECG;
D O I：
10.1016/j.thromres.2014.06.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [1] Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillation
    Yee C Lau
    Gregory YH Lip
    Pilar Gallego
    Hypertension Research, 2014, 37 : 699 - 700
  • [2] Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillation
    Lau, Yee C.
    Lip, Gregory Y. H.
    Gallego, Pilar
    HYPERTENSION RESEARCH, 2014, 37 (07) : 699 - 700
  • [3] Risk stratification for ischemic stroke and major bleeding in patients without atrial fibrillation - application of CHA2DS2-VASc and HAS-BLED scores
    Nakano, M.
    Kondo, Y.
    Nakano, M.
    Kajiyama, T.
    Ito, R.
    Takahira, H.
    Kitagawa, M.
    Sugawara, M.
    Chiba, T.
    Kobatashi, Y.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2073 - 2073
  • [4] Refining stroke and bleeding risk prediction by adding consecutive biomarkers to CHA2DS2-VASc and HAS-BLED scores
    Rivera Caravaca, J. M.
    Esteve-Pastor, M. A.
    Vilchez, J. A.
    Galvez, J.
    Vicente, V.
    Marin, F.
    Roldan, V.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 821 - 822
  • [5] Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF MEDICINE, 2011, 124 (02): : 111 - 114
  • [6] CHA2DS2-VASc and has-BLED scores do not accurately stratify risk for stroke or bleed in fall victims with atrial fibrillation
    Carr, Bryan W.
    Wooster, Meghan E.
    Nemani, Lakshmi A.
    Severance, Sarah E.
    Hartwell, Jennifer L.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 51 : 119 - 123
  • [7] Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study)
    Jaakkola, Samuli
    Kiviniemi, Tuomas O.
    Nuotio, Ilpo
    Hartikainen, Juha
    Mustonen, Pirjo
    Palomaki, Antti
    Jaakkola, Jussi
    Ylitalo, Antti
    Hartikainen, Paivi
    Airaksinen, K. E. Juhani
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (10): : 1182 - 1186
  • [8] Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    CIRCULATION, 2012, 126 (07) : 860 - 865
  • [9] CHA2DS2-VASc and HAS-BLED risk scores and real-world oral anticoagulant prescribing decisions in atrial fibrillation
    Besford, Megan
    Leahy, Thomas P.
    Sammon, Cormac
    Ulvestad, Maria
    Carroll, Robert
    Mehmud, Faisal
    Alikhan, Raza
    Ramagopalan, Sreeram
    FUTURE CARDIOLOGY, 2021, 17 (05) : 855 - 864
  • [10] Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients
    Serna, Maria Jose
    Rivera-Caravaca, Jose Miguel
    Lopez-Galvez, Raquel
    Soler-Espejo, Eva
    Lip, Gregory Y. H.
    Marin, Francisco
    Roldan, Vanessa
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (10): : 835 - 842
12345